Metraipolis › archive › dc_b650981950cd

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison — Europe PMC PMID:42319369

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42319369
DOI
10.57264/cer-2026-0069
License (as archived)
solo-consultazione
Archived
2026-10-19T07:59:28.057Z
SHA-256 of the archived text
f8f99540451b4bf3e62e87cba4ec90246e080e0ae49464a508197527b906add4
Stable URL of this page
https://metraipolis.com/documento/dc_b650981950cd

How to cite

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison — Europe PMC PMID:42319369 — Europe PMC (en), https://europepmc.org/article/MED/42319369 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b650981950cd (Metraipolis archive dc_b650981950cd, sha256 f8f99540451b4bf3e62e87cba4ec90246e080e0ae49464a508197527b906add4)
BibTeX
@misc{dcb650981950cd,
  title = {Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison — Europe PMC PMID:42319369},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42319369},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b650981950cd; sha256 f8f99540451b4bf3e62e87cba4ec90246e080e0ae49464a508197527b906add4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42319369. Agents can read the archived copy with the MCP tool read_document.